Many compare Protgenic´s to the “NASA of medicine”

We know that the world is changing, we do not want to change to adapt to the world, we want to change the world.

Access to Medicines

Responsibility

Our core responsibility in life is “to increase life”, we want to change your genome so we can change your destiny.

Partnership

The backbone of Protgenic´s —that is the role of scientists who commit to serving human progress with us . When you say you will support us, automatically the greatest Pharma Industry is behind you . Protgenic's everyday grows stronger.

Sustainability

Each of us is in the stock market and our shares rise or fall according to our performance. We have become a brand, We are sure that the performance of the company in the sum of the performance of each of us (internal and external customers).

Adaptability

Many compare Protgenic´s to the “NASA of medicine” and the comparison to its facilities is quite consistent: there are laboratories with the latest state-of-the-art technology. Every six months we renew equipment. We know that the world is changing. We do not want to change to adapt to the world, we want to change the world

We want to change your genome so we can change your destiny

The Protgenic´s Code of Ethics requires compliance with biological, psichologycal and production laws.

Lear more about us

We are different, because we think we all are equal.

Protgenic's is divided into five separate areas and each functions as a small business unit:

Bionanotechnology and cell surgery

Bionanotechnology as a branch of nanotechnology depends on biological materials and designs applied in medicine with cell surgery techniques.

Cell physiology

Cell physiology applies te study of normal function of cell membrane primarly and the different organelles involved in cell homeostasis

Stem cell

Stem cells have potential to develop into many different cell types, these cells are distinguished from other cells by two important characteristics:

1) They are unspecialized and capable of renewing themselves.
2) They can be induced to become organ-specific cells

Proteome department

The proteome is the entire set of proteins which varies rapidly in different situations that a cell or organism undergoes

Pharma

We produce, and market the pharmaceutical drugs for use as medications, based on research, ethics, development, GCPs and GPPs.

Products

Protgenic´s seeks to develop products that represent advancements by offering enhanced modes of delivery, more convenient treatment regimens, improved resistance profiles, reduced side effects and greater efficacy.

SLH

Sylophyline

Met21

Non-coding RNA 2-IST

DupX

Protgenic´s Duplication kit®

Myoclone Myohaler

Artificial muscle tropomyosin isoform exons®

Vib411

Resonancine

PAS20-21

Axantavinite

Fintinelle

Religious Abuse Syndrome

Exacloo

Anti-Aging

Apopcin

Abortive

Shallowtrim

Internet Addiction Disorder

C-Myosile

Heart Failure

Research & Development

Scientific breakthroughs are most likely to occur when scientists are free to tackle problems from different angles and in different ways.
Our scientists have this freedom.

Genetic in the world

Protgenic´s in action

The backbone of Protgenic´s. When you say you will support us, automatically the greatest Pharma Industry is behind you.

"Protgenic's everyday grows stronger" Our core responsibility in life is “to increase life”, we want to change your genome so we can change your destiny.

Many compare Protgenic´s to the “NASA of medicine” We know that the world is changing , We do not want to change to adapt to the world, we want to change the world.

Learn more about us

Worldwide Population Index

Nervous system diseases are a major public health challenge and, combined, one of the largest causes of disability worldwide.

53% Obesity

.13% Down Syndrome

Turner síndrome .05 % of women

73% Depression

25% Panic Attack Disorder

93% Religious Abuse Syndrome

68% Internet  Addiction Disorder

2% Heart Failure

We are apassionate about science; yours and ours

Kim Tae Jung MD

Bionanotechnology Global Director

Kim Tae Jung is currently Head of Protgenic´s Global Bionanotechnology and Adjunct Professor at Kamilya University School of Medicine. His current research focuses on cell surgery and regenerative medicine in blastomere membranes.

Nagy Rackosy PhD.

Cell surgery Global Manager

After obtaining his PhD, Rakosy became a fellow of Harvard College, working in biochemistry and cell biology with funding from the Banking Science Research Foundation. She investigates the genome sequence of the coelacanth, now she is the Project Manager of the Cell Surgery Department in Protgenic´s Europe.

Fausto Escobar MD.

Medical Excelence Manager LatAm

Dr. Fausto Escobar is the pioneer of genetics in Latin America, his research on sexual differentiation and Malformation Records make him one of the icons of genetics in the Hispanic world, currently is the Medical Excellence Manager in Protgenic's America.

Roberto Orea Fladder MD

Regional CSO

Dr. Roberto Orea Fladder is a Mexican medical doctor and scientist. He is currently Head of Protgenic's America, His research with Dr Kimura led him to discover Sylopyline (Brand name SLH) which is believed to be the most widely used medication for Obesity. Last year, SLH contributed $121 billion of Protgenic's $312.11 billion in total revenue.

Contact Info

Protgenic's Europe
Kalashnyy Pereulok, 12 0
Moscow 125009 Rusia
P: (123) 456-7890